Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression
Cannabis and Cannabinoid Research · 2025
DOI: 10.1089/can.2025.0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2025. Verfasst von Marisa S Briones und 2 weiteren Autor:innen. Beteiligte Einrichtung: BDH Pharma, LLC, Studio City, California, USA. Hauptthemen laut MEDLINE: Cannabidiol, Respiratory Insufficiency, Buprenorphine, Analgesics, Opioid. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BDH Pharma, LLC, Studio City, California, USA.
ORCID-Profile: Marisa S Briones
Förderung
- NIDA NIH HHS
Zitieren
APA
Briones, M. S., DeYoung, D. Z., & Heinzerling, K. G. (2025). Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2025.0004
Vancouver
Briones MS, DeYoung DZ, Heinzerling KG. Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression. Cannabis and Cannabinoid Research. 2025. doi:10.1089/can.2025.0004
BibTeX
@article{Briones2025,
author = {Briones, Marisa S and DeYoung, Dustin Z and Heinzerling, Keith G},
title = {Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression},
journal = {Cannabis and Cannabinoid Research},
year = {2025},
doi = {10.1089/can.2025.0004}
}
EUVIMED